Cargando…
Erythrocyte G Protein as a Novel Target for Malarial Chemotherapy
BACKGROUND: Malaria remains a serious health problem because resistance develops to all currently used drugs when their parasite targets mutate. Novel antimalarial drug targets are urgently needed to reduce global morbidity and mortality. Our prior results suggested that inhibiting erythrocyte G(s)...
Autores principales: | Murphy, Sean C, Harrison, Travis, Hamm, Heidi E, Lomasney, Jon W, Mohandas, Narla, Haldar, Kasturi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716186/ https://www.ncbi.nlm.nih.gov/pubmed/17194200 http://dx.doi.org/10.1371/journal.pmed.0030528 |
Ejemplares similares
-
Simultaneous adjunctive treatment of malaria and its coevolved genetic disorder sickle cell anemia
por: Safeukui, Innocent, et al.
Publicado: (2023) -
The Malarial Host-Targeting Signal Is Conserved in the Irish Potato Famine Pathogen
por: Bhattacharjee, Souvik, et al.
Publicado: (2006) -
Evidencing the Role of Erythrocytic Apoptosis in Malarial Anemia
por: Totino, Paulo R. R., et al.
Publicado: (2016) -
Erythrocyte tropism of malarial parasites: The reticulocyte appeal
por: Leong, Yew Wai, et al.
Publicado: (2022) -
Recognition of a 170 kD protein in mammalian Golgi complexes by an antibody against malarial intraerythrocytic lamellae
por: Li, Wenlu, et al.
Publicado: (1995)